pyrrolidonecarboxylic acid and Brain Edema

pyrrolidonecarboxylic acid has been researched along with Brain Edema in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Andersen, SW; Apostolova, LG; Ardayfio, PA; Brys, M; Duggan Evans, C; Lo, AC; Mintun, MA; Salloway, SP; Shcherbinin, S; Sims, JR; Skovronsky, DM; Sparks, J; Wessels, AM	1
Fathali, N; Hasegawa, Y; Khatibi, NH; Lekic, T; Manaenko, A; Martin, R; Tang, J; Zhang, JH	1
Lekic, T; Manaenko, A; Tang, J; Zhang, JH	1

Trials

1 trial(s) available for pyrrolidonecarboxylic acid and Brain Edema

Article	Year
Donanemab in Early Alzheimer's Disease. The New England journal of medicine, 2021, 05-06, Volume: 384, Issue:18 Topics: Activities of Daily Living; Administration, Intravenous; Aged; Alzheimer Disease; Brain Edema; Cognition; Disease Progression; Double-Blind Method; Epitopes; Female; Humans; Male; Mental Status and Dementia Tests; Plaque, Amyloid; Pyrrolidonecarboxylic Acid; Severity of Illness Index	2021

Article

Year

Donanemab in Early Alzheimer's Disease.

The New England journal of medicine, 2021, 05-06, Volume: 384, Issue:18

Topics: Activities of Daily Living; Administration, Intravenous; Aged; Alzheimer Disease; Brain Edema; Cognition; Disease Progression; Double-Blind Method; Epitopes; Female; Humans; Male; Mental Status and Dementia Tests; Plaque, Amyloid; Pyrrolidonecarboxylic Acid; Severity of Illness Index

2021

Other Studies

2 other study(ies) available for pyrrolidonecarboxylic acid and Brain Edema

Article	Year
Arginine-vasopressin V1a receptor inhibition improves neurologic outcomes following an intracerebral hemorrhagic brain injury. Neurochemistry international, 2011, Volume: 58, Issue:4 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Behavior, Animal; Blood Gas Analysis; Blood Pressure; Brain Edema; Cerebral Hemorrhage, Traumatic; Dose-Response Relationship, Drug; Indoles; Male; Mice; Neuropsychological Tests; Oligopeptides; Pyrrolidines; Pyrrolidonecarboxylic Acid	2011
NC1900, an arginine vasopressin analogue, fails to reduce brain edema and improve neurobehavioral deficits in an intracerebral hemorrhagic stroke mice model. Acta neurochirurgica. Supplement, 2011, Volume: 111 Topics: Analysis of Variance; Animals; Aquaporin 4; Arginine Vasopressin; Basal Ganglia; Brain Edema; Cerebral Hemorrhage; Collagenases; Disease Models, Animal; Exploratory Behavior; Functional Laterality; Gait Disorders, Neurologic; Male; Mice; Movement Disorders; Oligopeptides; Pyrrolidonecarboxylic Acid; Time Factors	2011

Article

Year

Arginine-vasopressin V1a receptor inhibition improves neurologic outcomes following an intracerebral hemorrhagic brain injury.

Neurochemistry international, 2011, Volume: 58, Issue:4

Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Behavior, Animal; Blood Gas Analysis; Blood Pressure; Brain Edema; Cerebral Hemorrhage, Traumatic; Dose-Response Relationship, Drug; Indoles; Male; Mice; Neuropsychological Tests; Oligopeptides; Pyrrolidines; Pyrrolidonecarboxylic Acid

2011

NC1900, an arginine vasopressin analogue, fails to reduce brain edema and improve neurobehavioral deficits in an intracerebral hemorrhagic stroke mice model.

Acta neurochirurgica. Supplement, 2011, Volume: 111

Topics: Analysis of Variance; Animals; Aquaporin 4; Arginine Vasopressin; Basal Ganglia; Brain Edema; Cerebral Hemorrhage; Collagenases; Disease Models, Animal; Exploratory Behavior; Functional Laterality; Gait Disorders, Neurologic; Male; Mice; Movement Disorders; Oligopeptides; Pyrrolidonecarboxylic Acid; Time Factors

2011